Actively Recruiting
An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders
Led by Children's Hospital of Fudan University · Updated on 2026-03-25
1500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of magnetoencephalography (MEG) to diagnose various neurodevelopmental disorders in children. These conditions include epilepsy, intracranial tumors, cerebrovascular diseases, autism, mental retardation, attention deficit hyperactivity disorder (ADHD), tic disorder, and other neuropsychiatric disorders. The study aims to observe how MEG can help locate epileptic regions and brain functional areas to support diagnosis in pediatric patients. This observational study involves children with neurodevelopmental diseases and healthy children as comparison groups. Participants undergo MEG, a non-invasive imaging technique that measures brain activity. The study does not involve experimental treatments but focuses on assessing MEG's diagnostic value. During the study, researchers will measure differences in MEG signals between affected children and healthy controls over three years. Participants will be monitored and evaluated through MEG exams, with attention to their ability to cooperate during the procedure. The study is conducted at a single center and spans from September 2024 to December 2027, with assessments aimed at better understanding MEG's role in diagnosing pediatric neurodevelopmental conditions.
CONDITIONS
Brief Title
Magnetoencephalography in Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 1 month to 18 years old
- Diagnosis of epilepsy
- Diagnosis of intracranial tumors
- Diagnosis of cerebrovascular diseases
- Diagnosis of autism
- Diagnosis of mental retardation
- Diagnosis of ADHD (Attention Deficit Hyperactivity Disorder)
- Diagnosis of tic disorder
- Diagnosis of neuropsychiatric disorders
You will not qualify if you...
- Unable to cooperate with the magnetoencephalography (MEG) exam
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single assessment
Participants undergo magnetoencephalography (MEG) to observe brain activity related to neurodevelopmental disorders.
1 visit (in-person)
Duration - Up to 3 years
Participants are observed over time to track MEG signal differences between children with neurodevelopmental diseases and healthy children.
Periodic visits depending on study schedule
Trial Site Locations
Total: 1 location
1
Children's Hospital of Fudan University
Shanghai, China, 201102
Actively Recruiting
Research Team
Y
Yuanfeng Zhou
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here